Substituted γ-lactone compounds as NMDA-antagonists
US6956055B2 · kind B2 · utility
12Cited by
0References
44Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 5, 2004 |
| Grant date | Oct 18, 2005 |
| Priority date | — |
| Expiry date | Jan 5, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to substituted γ-lactone compounds, to methods for the production thereof, to medicaments containing these compounds and to the use of these compounds for producing medicaments.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.